Rameda's profits drop to EGP 31M ending Sept. 2019
Updated 12/4/2019 4:50:57 PM
ArabFinance: Rameda Pharmaceutical (RMDA) announced in a statement sent to EGX, the audited financial results for the fiscal period starting January 1, 2019, and ending Sept. 30, 2019.
The company posted consolidated net profits of EGP 31,144,396, compared to net profits of EGP 76,641,548 in the same period a year ago, taking into account the minority rights.
Moreover, it posted standalone net profits of EGP 31,970,767, compared to net profits of EGP 75,362,724 in the same period last year.
